• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EZ GLIDE AORTIC CANNULA; CATHETER, CANNULA AND TUBING, VASCULAR, CARDIOPULMONARY BYPASS25

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EZ GLIDE AORTIC CANNULA; CATHETER, CANNULA AND TUBING, VASCULAR, CARDIOPULMONARY BYPASS25 Back to Search Results
Model Number EZS21TA
Device Problems Fluid/Blood Leak (1250); Material Integrity Problem (2978)
Patient Problem Hemorrhage/Bleeding (1888)
Event Date 09/03/2020
Event Type  Injury  
Manufacturer Narrative
(b)(4).Device evaluation- the device has been returned to edwards for evaluation.It is pending evaluation.Upon completion of the evaluation a supplemental mdr will be submitted.Attempts to retrieve additional information has been unsuccessful.If additional information is received a supplemental mdr will be submitted.These cannulae are used to divert large volumes of blood between the patient circulation and the cardiopulmonary bypass machine during cardiac surgery and, on occasion, ecmo (off-label use).This malfunction/defect would likely require an exchange of the cannula resulting in a temporary interruption of bypass and possibly significant blood loss.The cause of the event cannot be determined.Edwards will continue to review and monitor all events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Event Description
Edwards received information regarding an 21 arterial cannula.Patient arrived @ approx 2315 from or on va ecmo w/ open chest.Per surgical team/anesthesia attending, bleeding and rv failure in or as well as prolonged/multiple pump runs.Patient w/ blood seeping from under esmark/ioban on arrival.Required continuous infusion of blood products/fluid for maintaining bp/ecmo flows.Bleeding from around esmark/ioban increased greatly throughout next few hours.Decision made @ approx 0300 to perform emergent chest exploration/washout.Upon exploration, aortic cannula found to have multiple holes/cracks in cannula.Cannula exchanged with improved hemostasis and hemodynamics.There were no abnormalities with the placement of the cannula.Appears to be a cannula defect.Clarified line defect for ecmo- line was not cracked, but 2 small holes were visualized after item was removed from patient.Patient experienced progressive bleeding attributed to coagulopathy and the holes (unknown what time the holes developed).
 
Manufacturer Narrative
H11.Corrected data: device has been returned to edwards for evaluation as is pending evaluation.A supplemental mdr will be submitted upon receipt of additional information.H3 and d10.
 
Manufacturer Narrative
H10.Additional manufacturer narrative: the device history record (dhr) was reviewed and shows that this device met all manufacturing specifications for product release prior to distribution.No issues were identified that would have impacted this event.
 
Manufacturer Narrative
H3.Device evaluation: the device was returned to edwards for evaluation.Customer complaint of "hole/crack" and leakage on the cannula was confirmed with assessment.Device was returned with visible traces of blood and examined in the biohazard area of the lab.A leak test was performed on the catheter at 420mmhg.Multiple leakages were observed on the wire reinforced section of the cannula body.No other visual damage, contamination, or other abnormalities were found to the device.H10.Additional manufacturer narrative: the complaint was confirmed.The cause of the event cannot be determined at this time as further investigation is being performed.A supplemental mdr will be submitted when new information is learned.
 
Manufacturer Narrative
H10.Additional manufacturer narrative: the event was traced to component failure.The root cause of the event cannot be determined at this time.Added h6 result and conclusion code.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EZ GLIDE AORTIC CANNULA
Type of Device
CATHETER, CANNULA AND TUBING, VASCULAR, CARDIOPULMONARY BYPASS25
Manufacturer (Section D)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
MDR Report Key10885431
MDR Text Key217717891
Report Number3008500478-2020-00213
Device Sequence Number1
Product Code DWF
Combination Product (y/n)N
PMA/PMN Number
K123370
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 10/29/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/20/2023
Device Model NumberEZS21TA
Device Catalogue NumberEZS21TA
Device Lot Number258770
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/16/2020
Initial Date Manufacturer Received 10/29/2020
Initial Date FDA Received11/23/2020
Supplement Dates Manufacturer Received12/14/2020
12/16/2020
01/06/2021
01/27/2021
Supplement Dates FDA Received12/14/2020
01/05/2021
01/18/2021
02/01/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Life Threatening;
Patient Age63 YR
-
-